Dynamic quotes: Off
|
Company Description (as filed with the SEC)
Abaxis, Inc. (“Abaxis,” “us” or “we”) develops, manufactures, markets and sells portable blood analysis systems for use in the human or veterinary patient-care setting to provide clinicians with rapid blood constituent measurements. Abaxis was incorporated in California in 1989. Our principal offices are located at 3240 Whipple Road, Union City, California 94587. Our telephone number is (510) 675-6500 and our Internet address is www.abaxis.com. Our common stock trades on the NASDAQ Global Market under the symbol “ABAX.” OUR INDUSTRY: IN VITRO DIAGNOSTIC TESTING We believe that a key element of the patient-centered, cost-constrained health care system in the current year and beyond will be the availability of blood analysis systems in the patient care setting that are easily and reliably operated by caregivers and that provide accurate, real time results to enable rapid clinical decisions. ... More ...
Analyst Info |
|
| Annual EPS Est: | $1.23 |
| Quarterly EPS Est: | 0.23 |
| PEG Ratio: | 2.34 |
|
Mean Recommendation: View Summary / View All |
2.5 |
Data is provided by Zacks Investment Research

